Asthma is thought to be one of the most common causes of chronic cough. After some basic diagnostic workup, is it reasonable to start a trial of inhaled corticosteroids in most patients? Or should each patient with suspected asthma undergo a bronchial provocation test or another specialist test?
Are there any clinical situations in which the use of biologics is necessary in patients with asthma?
Are there any potential benefits of performing and repeating chest x-rays in asymptomatic elderly smokers?
Is the automated cough detection system commercially available and useful for clinicians outside specialist centers?
What is your opinion on the use of biologics in patients with asthma–chronic obstructive pulmonary disease overlap syndrome?
How can we monitor cough in clinical practice? Is there a place for questionnaires or cough monitors outside specialist centers, maybe even in general practitioners’ offices?
Some current lung cancer screening programs have simplified inclusion criteria, limited to age over 55 years and significant exposure to tobacco smoke. Do you think such criteria are appropriate?
Is it likely that in the near future the knowledge on chronic obstructive pulmonary disease (COPD) phenotypes will help to choose an optimal treatment?
Since our talk last year at MIRCIM 2016, have there been any new studies on noninvasive ventilation with clinically important conclusions?
What studies, in addition to chest x-ray and spirometry, should be performed in outpatients presenting with chronic cough? When should such patients be referred to specialist centers?
English
Polski
Español
українська